Skip to main content

Roche vs Xiaomi: Founders, CEOs and History

Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker. Xiaomi was founded in 2010 by Lei Jun, Lin Bin and is led by Lei Jun.

Company facts

Roche

Founded
1896
Headquarters
Basel, Switzerland
Current CEO
Thomas Schinecker
Employees
112,774

Xiaomi

Founded
2010
Headquarters
Beijing, China
Current CEO
Lei Jun
Employees
56,531

Founders

Roche

  • Fritz Hoffmann-La Roche

    Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.

Roche founders in full

Xiaomi

  • Lei Jun

    Lei Jun founded Xiaomi in 2010 and is its chairman and CEO. He set the company's early strategy of selling well-specified phones online at low prices, built the MIUI user community, and later led Xiaomi's 2018 Hong Kong listing.

  • Lin Bin

    Lin Bin co-founded Xiaomi in 2010 and served as its president, overseeing early phone development and supply-chain relationships. He handed the president role to others in 2019 and continued as vice chairman of the board.

Xiaomi founders in full

CEOs and their tenures

Roche

  1. Severin Schwan2008–2023

    Chief Executive Officer

    Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.

    Source
  2. Thomas Schinecker2023–present

    Chief Executive Officer

    Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.

    Source
Roche CEO history in full

Xiaomi

  1. Lei Jun2010–present

    Founder, Chairman and CEO

    Sets Xiaomi's product and ecosystem strategy and leads the EV business.

    Source
  2. Lin Bin2010–present

    Co-founder and Vice Chairman

    Co-founded Xiaomi with Lei Jun and served as president during its early growth before moving to the vice chairman role.

    Source
  3. Lu Weibing2022–present

    President

    Runs day-to-day operations of the group, having earlier led the Redmi brand and international business.

    Source
Xiaomi CEO history in full

Timeline: Roche and Xiaomi side by side

  1. 1896Roche

    F. Hoffmann-La Roche Founded in Basel

    Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.

  2. 1898Roche

    Commercial Breakthrough with Sirolin

    Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.

  3. 1934Roche

    First Industrial Synthesis of Vitamin C

    Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.

  4. 1963Roche

    Launch of Valium (Diazepam)

    Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.

  5. 1968Roche

    Establishment of Roche Diagnostics

    Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.

  6. 2008Roche

    Severin Schwan becomes CEO

    Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.

  7. 2009Roche

    Full Acquisition of Genentech for $46.8 Billion

    Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.

  8. 2010Xiaomi

    Xiaomi Founded

    Lei Jun and seven co-founders establish Xiaomi in Beijing and release the MIUI Android software.

  9. 2011Xiaomi

    Mi 1 Launches

    Xiaomi launches its first smartphone, sold online.

  10. 2014Xiaomi

    India Entry and $45B Valuation

    Xiaomi enters India and raises funding at a reported $45B valuation.

  11. 2018Roche

    Foundation Medicine & Flatiron Health Acquisitions

    Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.

  12. 2018Xiaomi

    Hong Kong IPO

    Xiaomi lists on the Hong Kong Stock Exchange under stock code 1810 with a weighted voting rights structure.

  13. 2021Xiaomi

    EV Entry Announced

    Xiaomi announces it will build electric vehicles and sets up a dedicated EV subsidiary.

  14. 2021Xiaomi

    Acquired DeepMotion

    Xiaomi acquired DeepMotion for $77 million. Autonomous-driving technology company acquired to support Xiaomi's EV program.

  15. 2023Roche

    Acquired Telavant

    F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.

  16. 2024Xiaomi

    SU7 Launch

    Xiaomi launches the SU7 electric sedan in March 2024 and begins deliveries.

  17. 2025Roche

    Group Sales Reach CHF 61.5 Billion

    Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.

  18. 2025Xiaomi

    Record Year and YU7 Launch

    Xiaomi launches the YU7 SUV, delivers 411,082 vehicles, and reports FY2025 revenue of ~$63.6B (RMB457.3B).

  19. 2026Xiaomi

    Memory Costs Hit Profit

    Q1 revenue falls 10.9% to ~$13.8B (RMB99.1B) and Q2 revenue falls 6.1% to ~$15.1B (RMB108.9B) as memory-chip costs squeeze margins.

Acquisitions

Roche

  • PathAI2026$1.1B
  • 89bio2025$3.5B
  • Telavant2023$7.1B
  • Carmot Therapeutics2023$2.7B
  • Foundation Medicine2018$2.4B
  • ForSight VISION42017Undisclosed
All Roche acquisitions

Questions about Roche vs Xiaomi

Who is the CEO of F. Hoffmann-La Roche AG and Xiaomi Corp.?

F. Hoffmann-La Roche AG is led by Thomas Schinecker and Xiaomi Corp. is led by Lei Jun. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was F. Hoffmann-La Roche AG founded vs Xiaomi Corp.?

F. Hoffmann-La Roche AG was founded in 1896 — 114 years before Xiaomi Corp., which was founded in 2010. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Xiaomi Corp..

How many employees does F. Hoffmann-La Roche AG have compared to Xiaomi Corp.?

F. Hoffmann-La Roche AG employs approximately 112,774 people, while Xiaomi Corp. employs approximately 56,531. F. Hoffmann-La Roche AG has the larger workforce at 112,774 employees, compared to Xiaomi Corp.'s 56,531. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are F. Hoffmann-La Roche AG and Xiaomi Corp. headquartered?

F. Hoffmann-La Roche AG is headquartered in Switzerland and Xiaomi Corp. is headquartered in China. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded F. Hoffmann-La Roche AG and Xiaomi Corp.?

F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche. Xiaomi Corp. was founded by Lei Jun, Lin Bin.

Which company has a longer operating history — F. Hoffmann-La Roche AG or Xiaomi Corp.?

F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Xiaomi Corp. has been in operation for around 16 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Roche vs Xiaomi overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.